Medicine & healthcare

Trump Imposes 100% Tariffs on Patented Drugs

Are Trump's drug tariffs powerful leverage against Big Pharma or political theater that ignores the real middlemen driving up prices?

Published APR 3

Trump Imposes 100% Tariffs on Patented Drugs

story

Above: U.S. President Donald Trump at the White House in Washington, DC, on Friday, Dec. 19, 2025. Image credit: Will Oliver/EPA/Bloomberg/Getty Images

The Spin

Pro-Trump narrative

Trump's 100% tariff on patented drugs is exactly the kind of hardball that forces Big Pharma to the table — companies either offer Americans the lowest prices or commit to building plants domestically, plain and simple. The policy already secured $400 billion in domestic manufacturing investments and gives firms a clear path to compliance. This is leverage that actually works.

Trump White House

Eric Daugherty on X

Anti-Trump narrative

These tariffs miss the real culprits — pharmacy benefit managers (PBMs) and specialty pharmacy middlemen. The FTC's own report caught PBM-affiliated pharmacies marking up generics by thousands of percent, yet tariffs leave that whole extraction layer completely untouched. Pressuring the front of the pipeline while ignoring the middle isn't a drug pricing fix — it's political theater that will ultimately burden Americans with higher prices as global supply chains are disrupted.

Jeffrey A. Singer on X

Special Interest Media on X